Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.
about
Systematic exploitation of multiple receptor conformations for virtual ligand screeningA statistical framework to evaluate virtual screening.Applications of integrated data mining methods to exploring natural product space for acetylcholinesterase inhibitors.Drug repositioning using in silico compound profiling.New in silico and conventional in vitro approaches to advance HIV drug discovery and design.A molecular-modeling toolbox aimed at bridging the gap between medicinal chemistry and computational sciences.Emerging topics in structure-based virtual screening.Streamlining hit discovery and optimization with a yoctoliter scale DNA reactor.In Silico Augmentation of the Drug Development Pipeline: Examples from the study of Acute Inflammation.Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicineRational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.Combating cystic fibrosis: in search for CF transmembrane conductance regulator (CFTR) modulators.High-throughput and in silico screenings in drug discovery.Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling.State-of-the-art and dissemination of computational tools for drug-design purposes: a survey among Italian academics and industrial institutions.Overview of computational methods employed in early-stage drug discovery.In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens.Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies.From natural products to drugs for epimutation computer-aided drug design.In Silico ADME/Tox PredictionsComputer- and Structure-Based Lead Identification for Epigenetic Targets
P2860
Q28478200-E89AA6A6-D18A-4FF0-BBBE-4A38DF982648Q33484416-D03275B9-2ECE-4A37-85DB-042BB9B9E710Q33538840-5F69D17A-7B4B-4897-B12D-1173FE54C2C2Q34172485-B4EE496A-C12E-4FEB-A579-B9CE47D2777EQ34483539-49D89E18-0B36-4007-AFD7-E472F9CCD425Q34560190-3B57321B-6656-4F04-BA50-B8412FD34214Q34610866-DDBD6963-56BD-4D17-AF8E-9C6664DDD6E5Q34616688-C99387A3-FDC5-4611-A4B2-775325EEFE32Q34908616-D8931C96-4801-433E-9F69-5C32D22C6636Q35036738-1500E7D6-9C91-4E65-9257-6DE21987499AQ36131284-20C73F46-7172-4362-B477-987C5C93232DQ37833017-E72BDE1B-ADB3-458D-8A9B-10AC58AE3926Q38088365-C9017B38-8203-4CF0-BD7F-B7FCCDFF97C6Q38655350-26B1741C-A026-4EC0-8B18-A550A0109B3EQ39417388-E91A0203-6C8A-4683-B866-DC2B37918993Q39991348-3B378A39-30B9-4891-B5E4-FE21F0A6BDDCQ42418733-12BD7B54-794E-4738-A1B6-FD20955A85ECQ51410824-A6D53B8B-56DA-4675-8CA1-C0DE2752B1DBQ51825702-0DECBED4-7916-4912-9505-284BE139EEABQ56984194-DD2B166F-C626-4B6A-ACF4-186D982F5A8DQ58860105-0F763076-4123-4B30-9A91-AF38D42E0624
P2860
Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancing drug discovery throu ...... rue positives retrieval rates.
@en
Enhancing drug discovery throu ...... rue positives retrieval rates.
@nl
type
label
Enhancing drug discovery throu ...... rue positives retrieval rates.
@en
Enhancing drug discovery throu ...... rue positives retrieval rates.
@nl
prefLabel
Enhancing drug discovery throu ...... rue positives retrieval rates.
@en
Enhancing drug discovery throu ...... rue positives retrieval rates.
@nl
P50
P1476
Enhancing drug discovery throu ...... true positives retrieval rates
@en
P2093
P304
P356
10.2174/092986708785132843
P577
2008-01-01T00:00:00Z